Artículo | 2024 |
ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy. The Spanish registry
|
BLOOD |
Artículo | 2024 |
Avatrombopag plus fostamatinib combination as treatment in patients with multirefractory immune thrombocytopenia
|
BRITISH JOURNAL OF HAEMATOLOGY |
Revisión | 2024 |
Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditions
|
AMERICAN JOURNAL OF HEMATOLOGY |
Artículo | 2024 |
Humanistic burden of haemophilia A without inhibitors: A cross-sectional analysis of the HemoLIFE study
|
HAEMOPHILIA |
Artículo | 2024 |
Multicenter assessment and longitudinal study of the prevalence of antibodies and related adaptive immune responses to AAV in adult males with hemophilia.
|
GENE THERAPY |
Artículo | 2024 |
Should we consider caplacizumab as routine treatment for acute thrombotic thrombocytopenic purpura? An expert perspective on the pros and cons.
|
EXPERT REVIEW OF HEMATOLOGY |
Nota | 2024 |
Sovleplenib in immune thrombocytopenia
|
LANCET HAEMATOLOGY |
Artículo | 2024 |
The seasonal distribution of immune thrombotic thrombocytopenic purpura is influenced by geography: Epidemiologic findings from a multi-center analysis of 719 disease episodes
|
AMERICAN JOURNAL OF HEMATOLOGY |
Nota | 2024 |
Thrombotic thrombocytopenic purpura: 100 years of research on Moschcowitz syndrome
|
BLOOD |
Artículo | 2024 |
Treatment with fostamatinib in patients with immune thrombocytopenia: Experience from the Andalusian region in Spain—The Fostasur Study
|
BRITISH JOURNAL OF HAEMATOLOGY |
Artículo | 2024 |
Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients.
|
JOURNAL OF CLINICAL MEDICINE |
Resumen congreso | 2023 |
ACQUIRED HAEMOPHILIA
|
HAEMOPHILIA |
Revisión | 2023 |
An update on the pathogenesis and diagnosis of thrombotic thrombocytopenic purpura
|
EXPERT REVIEW OF HEMATOLOGY |
Artículo | 2023 |
Autoimmune hemolytic anemia during pregnancy and puerperium: an international multicenter experience
|
BLOOD |
Resumen congreso | 2023 |
Avatrombopag Plus Fostamatinib Combination Efficacy and Safety in Patients with Immune Thrombocytopenia
|
BLOOD |
Resumen congreso | 2023 |
Caplacizumab Treatment in Elderly Patients with iTTP: Updated Experience from the Spanish TTP Registry
|
BLOOD |
Artículo | 2023 |
Efficacy and safety in patients with haemophilia A switching to octocog alfa (BAY 81-8973): Final results of the global real-world study, TAURUS
|
EUROPEAN JOURNAL OF HAEMATOLOGY |
Artículo | 2023 |
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
|
LANCET |
Artículo | 2023 |
Immune thrombotic thrombocytopenic purpura in older patients: Results from the Spanish TTP Registry (REPTT)
|
BRITISH JOURNAL OF HAEMATOLOGY |
Revisión | 2023 |
Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)
|
JOURNAL OF CLINICAL MEDICINE |
Revisión | 2023 |
Spanish registry of thrombotic thrombocytopenic purpura (REPTT): Data evidence and new developments
|
TRANSFUSION AND APHERESIS SCIENCE |
Letter | 2023 |
Successful use of thrombopoietin analogs in thrombocytopenia associated with MYH-9 mutation
|
ANNALS OF HEMATOLOGY |
Artículo | 2023 |
Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A
|
NEW ENGLAND JOURNAL OF MEDICINE |
Resumen congreso | 2022 |
Pttapp: An Application Developed By the Spanish Society of Hematology and Hemotherapy to Show Practical Recommendations on the Management of Immune TTP
|
BLOOD |
Revisión | 2022 |
Acquired Haemophilia A: A Review of What We Know
|
JOURNAL OF BLOOD MEDICINE |
Resumen congreso | 2022 |
ACQUIRED VON WILLEBRAND DISEASE AND CHRONIC LYMPHOCYTIC LEUKAEMIA: REMISSION AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
|
HAEMOPHILIA |
Artículo | 2022 |
Activated prothrombin complex concentrate to treat bleeding events in acquired hemophilia A: BAHAS study
|
EUROPEAN JOURNAL OF HAEMATOLOGY |
Resumen congreso | 2022 |
Anxiety and Depression in Patients with Haemophilia a without Inhibitors and Their Caregivers Included in Hemolife, Non Interventional Study in the Spanish Population
|
BLOOD |
Resumen congreso | 2022 |
Autoimmune Hemolytic Anemia during Pregnancy or Post-Partum: An International Multi-Center Experience
|
BLOOD |
Revisión | 2022 |
COVID-19 Vaccines and Autoimmune Hematologic Disorders
|
Vaccines |
Resumen congreso | 2022 |
Efficacy of thrombopoietin receptor agonists in Evans syndrome: An international multicentre experience
|
BRITISH JOURNAL OF HAEMATOLOGY |
Artículo | 2022 |
IX international curse of continuing formation in haemophilia and other congenital coagulopathies. The role of the Laboratory in coagulation disorders. Diagnosis of von Willebrand disease
|
BLOOD COAGULATION & FIBRINOLYSIS |
Artículo | 2022 |
New treatments for primary immune thrombocytopenia
|
BLOOD COAGULATION & FIBRINOLYSIS |
Revisión | 2022 |
Novel Therapies to Address Unmet Needs in ITP
|
PHARMACEUTICALS |
Artículo | 2022 |
Pharmacokinetic and clinical improvements after PK-guided switch from standard half-life to extended half-life factor VIII products
|
THROMBOSIS RESEARCH |
Artículo | 2022 |
Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura
|
Blood Advances |
Artículo | 2022 |
Recommendations for the diagnosis and treatment of patients with thrombotic thrombocytopenic purpura
|
MEDICINA CLINICA |
Letter | 2022 |
Thrombopoietin receptor agonists in adult Evans syndrome: an international multicenter experience
|
BLOOD |
Artículo | 2022 |
Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A
|
NEW ENGLAND JOURNAL OF MEDICINE |
Artículo | 2021 |
A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients
|
BLOOD CELLS MOLECULES AND DISEASES |
Resumen congreso | 2021 |
Contribution of Next Generation Flow (NGF) Cytometry in Primary Immune Thrombocytopenia (ITP): Utility for the Differential Diagnosis with Myelodysplastic Syndromes
|
BLOOD |
Resumen congreso | 2021 |
Cytopenias in CAR-T Cell Therapy and Use of Transfusion Resources in Adult Patients with Lymphoproliferative Disorders
|
BLOOD |
Corrección | 2021 |
Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia (vol 11, 16867, 2021)
|
Scientific reports |
Resumen congreso | 2021 |
Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplantation: A Retrospective Analysis
|
BONE MARROW TRANSPLANTATION |
Artículo | 2021 |
Evans syndrome in adults: an observational multicenter study
|
Blood Advances |
Resumen congreso | 2021 |
GetEfficacy of Thrombopoietin Receptor Agonists in Evans Syndrome: An International Multicenter Experience
|
BLOOD |
Artículo | 2021 |
Incidence, characteristics and clinical profile of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with pre-existing primary immune thrombocytopenia (ITP) in Spain
|
BRITISH JOURNAL OF HAEMATOLOGY |
Artículo | 2021 |
Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura
|
Journal of Clinical Apheresis |
Resumen congreso | 2021 |
INCREASE IN THE CONSUMPTION OF PLATELET POOLS IN A 30 LEVEL HOSPITAL: ANALYSIS AND OPTIMIZATION ROUTES
|
HAEMATOLOGICA |
Artículo | 2021 |
Management of acquired hemophilia A: results from the Spanish registry
|
Blood Advances |
Artículo | 2021 |
Real-World Rates of Bleeding, Factor VIII Use, and Quality of Life in Individuals with Severe Haemophilia A Receiving Prophylaxis in a Prospective, Noninterventional Study
|
JOURNAL OF CLINICAL MEDICINE |
Resumen congreso | 2021 |
RESULTS FROM A 52-WEEK, PROSPECTIVE, NONINTERVENTIONAL STUDY OF INDIVIDUALS WITH SEVERE HAEMOPHILIA A RECEIVING PROPHYLAXIS: RATES OF BLEEDING, FVIII USE, AND QUALITY OF LIFE
|
HAEMOPHILIA |
Resumen congreso | 2021 |
RESULTS FROM A PHASE 1/2 SAFETY AND DOSE ESCALATION STUDY OF TAK-754, AN AAV8 VECTOR WITH A CODON-OPTIMIZED B-DOMAIN-DELETED FACTOR VIII TRANSGENE IN SEVERE HEMOPHILIA A
|
HAEMOPHILIA |
Letter | 2021 |
The factor VIII treatment history of non-severe hemophilia A: COMMENT. Joint damage in adult patients with mild or moderate hemophilia A evaluated with the HEAD-US system
|
JOURNAL OF THROMBOSIS AND HAEMOSTASIS |
Artículo | 2021 |
Type 2N VWD: Conclusions from the Spanish PCM-EVW-ES project
|
HAEMOPHILIA |
Artículo | 2021 |
Ultrasound evaluation of joint damage and disease activity in adult patients with severe haemophilia A using the HEAD-US system
|
HAEMOPHILIA |
Artículo | 2020 |
Adherence to prophylaxis in adult patients with severe haemophilia A
|
HAEMOPHILIA |
Artículo | 2020 |
BAY 81-8973 prophylaxis and pharmacokinetics in haemophilia A: Interim results from the TAURUS study
|
EUROPEAN JOURNAL OF HAEMATOLOGY |
Resumen congreso | 2020 |
BAY 81-8973 PROPHYLAXIS IN PATIENTS WITH HAEMOPHILIA A: INTERIM FINDINGS FOR CHILDREN <12 YEARS FROM THE TAURUS REAL-WORLD STUDY
|
HAEMOPHILIA |
Resumen congreso | 2020 |
Caplacizumab As New Paradigm-Changing Therapy for Patients with Autoimmune Thrombotic Thrombocytopenic Purpura (aTTP): Real-World Data from TTP Spanish Registry
|
BLOOD |
Resumen congreso | 2020 |
DETERMINATION OF THE CHALLENGES AND OPPORTUNITIES ASSOCIATED WITH PLATELET TRANSFUSION IN THE MANAGEMENT OF PATIENTS WITH SEVERE THROMBOCYTOPENIA ASSOCIATED WITH CHRONIC LIVER DISEASE
|
HAEMATOLOGICA |
Resumen congreso | 2020 |
Development of an observatory of unmet needs and future trends on the management of people with hemophilia in Spain
|
HAEMOPHILIA |
Resumen congreso | 2020 |
DONOR LYMPHOCYTE INFUSION: RETROSPECTIVE ANALYSIS OF EXPERIENCE AND UTILITY IN A THIRD-LEVEL HOSPITAL
|
HAEMATOLOGICA |
Resumen congreso | 2020 |
ELTROMBOPAG VS ROMIPLOSTIN IN THE TREATMENT OF IMMUNE THROMBOCYTOPENIA. PRACTICAL ASPECTS
|
HAEMATOLOGICA |
Resumen congreso | 2020 |
Evans' Syndrome in Adults: An Observational Multicentre Study
|
BLOOD |
Artículo | 2020 |
General concepts on hemophilia A and on women carrying the disease
|
BLOOD COAGULATION & FIBRINOLYSIS |
Resumen congreso | 2020 |
GRANULOCYTOAPHERESIS IN INFLAMMATORY BOWEL DISEASE: SAFETY AND EFFICACY
|
HAEMATOLOGICA |
Artículo | 2020 |
Management of chronic liver disease-associated severe thrombocytopenia in Spain: A view from the experts
|
Revista Española de Enfermedades Digestivas |
Resumen congreso | 2020 |
PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTS
|
HAEMOPHILIA |
Resumen congreso | 2020 |
PK-guided switch from standard half-life to extended half-life factor VIII products
|
HAEMOPHILIA |
Artículo | 2020 |
Prophylaxis therapy with bypassing agents in patients with haemophilia A and inhibitors undergoing surgery: A cost analysis in Spain
|
EUROPEAN JOURNAL OF HAEMATOLOGY |
Resumen congreso | 2020 |
SPANISH REGISTRY OF PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA. ANALYSIS OF PATIENTS TREATED WITH CAPLACIZUMAB
|
HAEMATOLOGICA |
Resumen congreso | 2020 |
TEN YEARS OF EXPERIENCE IN THE TREATMENT OF PTT IN A THIRD LEVEL HOSPITAL
|
HAEMATOLOGICA |
Resumen congreso | 2020 |
THE HAEMOPHILIA OBSERVATORY IN SPAIN. A ROADMAP TOWARDS SHARED VALUE IN HAEMOPHILIA HEALTHCARE FROM A MULTIDISCIPLINARY AND PATIENT-ORIENTED PERSPECTIVE
|
VALUE IN HEALTH |
Artículo | 2020 |
Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort
|
THROMBOSIS AND HAEMOSTASIS |
Resumen congreso | 2019 |
Adherence to prophylaxis in adult patients with severe haemophilia A
|
HAEMOPHILIA |
Artículo | 2019 |
Clinical pattern of hemophilia and causes of variability
|
BLOOD COAGULATION & FIBRINOLYSIS |
Resumen congreso | 2019 |
Clinical results of continuous prophylaxis in patients with severe haemophilia after change in factor VIII of extended average lifespan
|
HAEMATOLOGICA |
Resumen congreso | 2019 |
Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products
|
BLOOD |
Artículo | 2019 |
Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia
|
Scientific reports |
Resumen congreso | 2019 |
Determinants of prophylaxis regimen choice for patients with haemophilia A switching to BAY 81-8973: Real-world findings from the TAURUS non-interventional study
|
HAEMOPHILIA |
Resumen congreso | 2019 |
DETERMINING THE EPIDEMIOLOGY, PATIENT FLOW, TREATMENT AND UNMET NEEDS OF PATIENTS WITH CHRONIC LIVER DISEASE-ASSOCIATED SEVERE THROMBOCYTOPENIA UNDERGOING INVASIVE PROCEDURES IN SPAIN
|
VALUE IN HEALTH |
Resumen congreso | 2019 |
Do Guidelines Influence Diagnostic and Therapeutic Practice in Immune Thrombocytopenia? Results of a Multicenter Retrospective Study
|
BLOOD |
Resumen congreso | 2019 |
Incidence, Diagnosis, and Outcome of Acquired Thrombotic Thrombocytopenic Purpura (aTTP): A Nationwide Survey By the Spanish Apheresis Group
|
BLOOD |
Resumen congreso | 2019 |
Influence of Age on Treatment with Thrombopoietin Receptor Agonists in Patients with Immune Thrombocytopenia; A Retrospective Multicenter Study
|
BLOOD |
Artículo | 2019 |
Involvement of antifactor VIII autoantibodies specificity in the outcome of inhibitor eradication therapies in acquired hemophilia a patients
|
BLOOD COAGULATION & FIBRINOLYSIS |
Artículo | 2019 |
Management of Adult Patients with Primary Immune Thrombocytopenia (ITP) in Clinical Practice: A Consensus Approach of the Spanish ITP Expert Group.
|
Advances in hematology |
Artículo | 2019 |
Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content
|
PLATELETS |
Resumen congreso | 2019 |
Predictive Factors for Thrombopoietin Receptor Agonist Free Responses in Chronic ITP Patients: A Multicenter Retrospective Study with Long-Term Follow-up
|
BLOOD |
Resumen congreso | 2019 |
PREDICTORS OF TREATMENT FREE RESPONSES WITH THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH PTI
|
HAEMATOLOGICA |
Resumen congreso | 2019 |
SPANISH REGISTRY OF ACQUIRED HEMOPHILIA, 5 YEARS OF ACTIVITY
|
HAEMATOLOGICA |
Resumen congreso | 2019 |
SWITCH ANALYSIS GUIDED BY PHARMACOKINETICS FROM FACTORS VIII OF STANDARD HALF LIFE TO EXTENDED HALF LIFE FACTORS
|
HAEMATOLOGICA |
Resumen congreso | 2019 |
TAURUS real-world study: Straightforward transition to BAY 81-8973 prophylaxis in patients with haemophilia A with maintained or reduced dosing frequency
|
HAEMOPHILIA |
Resumen congreso | 2019 |
THROMBOTIC EVENTS IN PATIENTS WITH PTI TREATED WITH THROMBOPOIETIN RECEPTOR AGONISTS. IDENTIFICATION OF PREDISPOSING FACTORS
|
HAEMATOLOGICA |
Artículo | 2019 |
Unraveling the effect of silent, intronic and missense mutations on VWF splicing: contribution of next generation sequencing in the study of mRNA
|
HAEMATOLOGICA |
Revisión | 2019 |
Update on Molecular Testing in von Willebrand Disease
|
SEMINARS IN THROMBOSIS AND HEMOSTASIS |
Artículo | 2018 |
Análisis de costes del tratamiento para pacientes con hemofilia A con inhibidor en España Analysis of treatment costs for hemophilia A patients with inhibitor in Spain
|
Pharmacoeconomics - Spanish Research Articles |
Resumen congreso | 2018 |
Determinants of Prophylaxis Regimen Choice for Patients with Hemophilia A Switching to Bay 81-8973: Real World Findings from the Taurus Non-Interventional Study
|
BLOOD |
Artículo | 2018 |
Improvement in clinical outcomes and replacement factor VIII use in patients with haemophilia A after factor VIII pharmacokinetic-guided prophylaxis based on Bayesian models with myPKFiT®
|
HAEMOPHILIA |
Capítulo | 2018 |
Inhibidores adquiridos de la coagulación
|
Hemostasia y trombosis: manual práctico |
Resumen congreso | 2018 |
Lymphoma under hospitalized chemotherapy schemes: Specific Thromboembolic Risk Factors and Venous thrombosis incidence
|
THROMBOSIS RESEARCH |
Letter | 2018 |
Moderate and severe haemophilia in Spain: An epidemiological update
|
HAEMOPHILIA |
Artículo | 2018 |
Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project
|
PLOS ONE |
Resumen congreso | 2018 |
Safety and efficacy of fascial therapy in the treatment of hemophilic arthropathy of elbow: a pilot study
|
HAEMOPHILIA |
Resumen congreso | 2018 |
Straightforward Transition to Bay 81-8973 Prophylaxis in Patients with Hemophilia A: Prospective Real-World Data from the Taurus Non-Interventional Study Show That Number of Infusions per Week Is Maintained or Reduced
|
BLOOD |
Artículo | 2018 |
The predictive value of factor VIII/factor IX levels to define the severity of hemophilia: communication from the SSC of ISTH
|
JOURNAL OF THROMBOSIS AND HAEMOSTASIS |
Artículo | 2018 |
Treatment characteristics, efficacy and safety of thrombopoietin analogues in routine management of primary immune thrombocytopenia
|
BLOOD COAGULATION & FIBRINOLYSIS |
Libro | 2018 |
Trombosis y hemostasia: XII curso de formación continuada
|
Trombosis y hemostasia: XII curso de formación continuada |
Revisión | 2017 |
Acquired haemophilia: Epidemiology, clinical presentation, diagnosis and treatment
|
MEDICINA CLINICA |
Resumen congreso | 2017 |
BYPASSING AGENTS PROPHYLAXIS IN PATIENTS WITH HAEMOPHILIA AND INHIBITORS UNDERGOING SURGERY: A DECISION ANALYSIS IN SPAIN
|
VALUE IN HEALTH |
Artículo | 2017 |
Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study
|
Hematology |
Artículo | 2017 |
Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A
|
THROMBOSIS AND HAEMOSTASIS |
Resumen congreso | 2017 |
COMBINED TREATMENT OF AZATHIOPRINE AND ROMIPLOSTIM IN PATIENTS ITP REFRACTORY TO STEROIDS OR THROMBOPOIETIN ANALOGS
|
HAEMATOLOGICA |
Resumen congreso | 2017 |
Influence of Inhibitor Characteristics on Response to Hemostatic and Immunosuppressive Treaments in Acquired Hemophilia Patients: The Ciha Project
|
BLOOD |
Artículo | 2017 |
Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients
|
HAEMATOLOGICA |
Artículo | 2017 |
Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case series
|
HAEMOPHILIA |
Resumen congreso | 2017 |
Outpatients with Lymphoma on Chemotherapy: Specific Thromboembolic Risk Factors and Venous Thrombosis Incidence
|
BLOOD |
Resumen congreso | 2017 |
REAL WORLD EVIDENCE ON DRUG UTILIZATION PATTERNS OF ELTROMBOPAG IN ADULT PATIENTS WITH IMMUNE THROMBOCYTOPENIA: REVIEU (REVOLADE™ [ELTROMBOPAG] IN SELECTED COUNTRIES IN THE EUROPEAN UNION) STUDY
|
HAEMATOLOGICA |
Resumen congreso | 2017 |
Successful Treatment of Bleeding in Acquired Hemophilia A with Activated Prothrombin Complex Concentrate in Spain
|
BLOOD |
Artículo | 2017 |
Sustained Remission in Patients with Primary Immune Thrombocytopenia after Romiplostim Tapering and Discontinuation: A Case Series in Real Life Management in Spain
|
CASE REPORTS IN HEMATOLOGY |
Resumen congreso | 2016 |
Characterization of Bleeding in Hemophilia Carriers and Comparison to Women with Type 1 Von Willebrand Disease, Type 3 Von Willebrand Disease Obligate Carriers and Controls
|
BLOOD |
Artículo | 2016 |
Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational study
|
HAEMOPHILIA |
Letter | 2016 |
FVIII inhibitor development according to concentrate: data from the EUHASS registry excluding overlap with other studies
|
HAEMOPHILIA |
Artículo | 2016 |
Hip Replacement Surgery in 14-Year-Old Girl with Factor V Deficiency: Haemostatic Treatment and Thromboprophylaxis
|
CASE REPORTS IN HEMATOLOGY |
Resumen congreso | 2016 |
Improved Clinical Outcomes and Replacement FVIII Consumption in Patients with Hemophilia a after Prophylaxis Adjustment Using a FVIII Pharmacokinetics Estimation Based on Bayesian Models
|
BLOOD |
Artículo | 2016 |
Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): Proposal for a new diagnostic paradigm
|
THROMBOSIS AND HAEMOSTASIS |
Revisión | 2016 |
Spanish consensus guidelines on prophylaxis with bypassing agents for surgery in patients with haemophilia and inhibitors
|
EUROPEAN JOURNAL OF HAEMATOLOGY |
Artículo | 2016 |
Spanish Consensus Guidelines on prophylaxis with bypassing agents in patients with haemophilia and inhibitors
|
THROMBOSIS AND HAEMOSTASIS |
Artículo | 2015 |
Adherence to prophylaxis and quality of life in children and adolescents with severe haemophilia A
|
HAEMOPHILIA |
Artículo | 2015 |
Adult severe haemophilia A patients under long-term prophylaxis with factor VIII in routine clinical practice
|
BLOOD COAGULATION & FIBRINOLYSIS |
Artículo | 2015 |
Cost analysis of prophylaxis with activated prothrombin complex concentrate vs. on-demand therapy with activated factor VII in severe haemophilia A patients with inhibitors, in Spain
|
HAEMOPHILIA |
Artículo | 2015 |
Coste por paciente con respuesta a romiplostim y rituximab en el tratamiento de la trombocitopenia inmune primaria en España
|
MEDICINA CLINICA |
Resumen congreso | 2015 |
Efficacy and Safety of Eltrombopag in Persistent and Newly Diagnosed ITP
|
BLOOD |
Artículo | 2015 |
Inhibitor development in non-severe haemophilia across Europe
|
THROMBOSIS AND HAEMOSTASIS |
Artículo | 2015 |
Presentation and management of acute coronary syndromes among adult persons with haemophilia: results of an international, retrospective, 10-year survey
|
HAEMOPHILIA |
Artículo | 2015 |
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia
|
AMERICAN JOURNAL OF HEMATOLOGY |
Artículo | 2015 |
Use of eltrombopag after romiplostim in primary immune thrombocytopenia
|
BRITISH JOURNAL OF HAEMATOLOGY |
Resumen congreso | 2015 |
Validation of the international society on thrombosis and haemostasis bleeding assessment tool (ISTH-BAT) in hemophilia carriers
|
JOURNAL OF THROMBOSIS AND HAEMOSTASIS |
Resumen congreso | 2014 |
Analysis of Bleeding Phenotype of Severe Hemophilia a Carriers and Comparation with a Working Population Group. Impact on Quality of Life
|
BLOOD |
Resumen congreso | 2014 |
Analysis of Hemorrhagic Phenotype and Cardiovascular Risk of Severe Hemophilia a Carriers and Difference with Female Working Population Control Group
|
BLOOD |
Resumen congreso | 2014 |
Application of Pharmacokinetics Programs in Optimization of Haemostatic Treatment in Severe Hemophilia a Patients: Changes in Consumption, Clinical Outcomes and Quality of Life
|
BLOOD |
Artículo | 2014 |
Comparación de guías internacionales sobre púrpura trombocitopénica autoinmunitaria primaria
|
MEDICINA CLINICA |
Resumen congreso | 2014 |
Indication, Resource Consumption and Clinical Outcomes of Prophylaxis in Adult Patients with Severe Hemophilia a in Routine Clinical Practice
|
BLOOD |
Revisión | 2014 |
Key issues in inhibitor management in patients with haemophilia
|
BLOOD TRANSFUSION |
Resumen congreso | 2014 |
Primary Immune Thrombocytopenia in Elderly Patients: Clinical Profile, Efficacy and Safety of Treatment Protocols
|
BLOOD |
Resumen congreso | 2014 |
Successful Discontinuation of Eltrombopag after Complete Remission in Patients with Primary Immune Thrombocytopenia
|
BLOOD |
Resumen congreso | 2014 |
Use of Eltrombopag after Romiplostim in Primary ITP Patients
|
BLOOD |
Resumen congreso | 2014 |
Validation of the International Society on Thrombosis and Haemostasis Bleeding Assessment Tool (ISTH-BAT) in Hemophilia Carriers
|
HAEMOPHILIA |
Resumen congreso | 2013 |
AURIGA: study of adherence to prophylaxis in patients with severe haemophilia A
|
JOURNAL OF THROMBOSIS AND HAEMOSTASIS |
Resumen congreso | 2013 |
Comprehensive assessment of hemorrhagic phenotype and cardiovascular risk profile in carriers of severe haemophilia
|
JOURNAL OF THROMBOSIS AND HAEMOSTASIS |
Artículo | 2013 |
Consenso nacional sobre el diagnóstico, estratificación de riesgo y tratamiento de los pacientes con tromboembolia pulmonar
|
ARCHIVOS DE BRONCONEUMOLOGIA |
Resumen congreso | 2013 |
Cost analysis of bypassing agent prophylaxis treatment versus on-demand therapy in hemophilia A with inhibitor in Spain
|
VALUE IN HEALTH |
Resumen congreso | 2013 |
First-LINE Treatment With High-Dose Dexamethasone Terapy For Adult Primary Inmune Thrombocytopenia
|
BLOOD |
Revisión | 2013 |
Global Emerging HEmophilia Panel (GEHEP): A Multinational Collaboration for Advancing Hemophilia Research and Treatment
|
TRANSFUSION MEDICINE AND HEMOTHERAPY |
Resumen congreso | 2013 |
Inhibitor characterization in acquired haemophilia and its influence on bleeding profiles and treatment response: CIHA-01 project
|
JOURNAL OF THROMBOSIS AND HAEMOSTASIS |
Resumen congreso | 2013 |
Registry of inhibitors in mild and moderate haemophilia A patients in Spain
|
JOURNAL OF THROMBOSIS AND HAEMOSTASIS |
Resumen congreso | 2013 |
Thrombopoietin Analogs In ITP Patients Daily Practice: Treatment Profile, Efficacy and Safety
|
BLOOD |
Resumen congreso | 2012 |
APLASTIC ANEMIA IN PATIENTS OVER 60 YEARS OLD: EFFECTIVENESS AND SAFETY OF TREATMENT PROFILES
|
HAEMATOLOGICA |
Resumen congreso | 2012 |
Aplastic Anemia: Effectiveness and Safety of Treatment Profiles Depending On Age
|
BLOOD |
Artículo | 2012 |
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
|
JOURNAL OF THROMBOSIS AND HAEMOSTASIS |
Editorial | 2012 |
Diagnóstico, tratamiento y seguimiento de la trombocitopenia inmune primaria
|
MEDICINA CLINICA |
Artículo | 2012 |
Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
|
BLOOD |
Artículo | 2012 |
Is on-demand treatment effective in patients with severe haemophilia?
|
HAEMOPHILIA |
Artículo | 2012 |
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry
|
BLOOD |
Artículo | 2012 |
Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry
|
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY |
Letter | 2012 |
The international factor IX treatment network survey
|
HAEMOPHILIA |
Resumen congreso | 2011 |
Dexamethasone vs. standard prednisone in patients with chronic ITP: results and preferences
|
JOURNAL OF THROMBOSIS AND HAEMOSTASIS |
Resumen congreso | 2011 |
Intracranial bleeding in patients with haemophilia and inhibitors
|
JOURNAL OF THROMBOSIS AND HAEMOSTASIS |
Artículo | 2011 |
Prophylaxis therapy in haemophilia A: current situation in Spain
|
HAEMOPHILIA |
Resumen congreso | 2011 |
Splenectomy, rituximab and romiplostim in chronic ITP: efficacy and safety profile
|
JOURNAL OF THROMBOSIS AND HAEMOSTASIS |
Artículo | 2010 |
Consensus recommendations for the diagnosis and treatment of acquired hemophilia A
|
BMC Research Notes |
Resumen congreso | 2010 |
Iliopsoas hematoma in patients with hemophilia and inhibitor
|
HAEMOPHILIA |
Resumen congreso | 2010 |
Integral assessment of hemophilia carriers: new guideline from Spanish Foundation Victoria Eugenia
|
HAEMOPHILIA |
Resumen congreso | 2010 |
Integral physiotherapeutic guidelines for hemophilia patients from Spanish Foundation Victoria Eugenia
|
HAEMOPHILIA |
Resumen congreso | 2010 |
Optimum response to treatment of immunotolerance with octocog alfa
|
HAEMOPHILIA |
Resumen congreso | 2010 |
Pharmacologic venous thromboembolism prophylaxis in haemophilic patients under major orthopaedic surgery: experience and safety profile
|
HAEMOPHILIA |
Artículo | 2010 |
Romiplostim: un gran avance en el tratamiento de la purpura trombocitopenica idiopatica
|
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY |
Resumen congreso | 2010 |
The Spanish Immune Tolerance Induction Registry: 2009 update
|
HAEMOPHILIA |
Resumen congreso | 2009 |
Evaluation of secondary prophylaxis with rfviia in hemophiliac patients with inhibitors
|
JOURNAL OF THROMBOSIS AND HAEMOSTASIS |
Resumen congreso | 2009 |
Hemophiliac patient serum bank: evaluation of the influence of emerging pathogens and infectious risks associated to replacement therapy after 2 years follow-up
|
JOURNAL OF THROMBOSIS AND HAEMOSTASIS |
Resumen congreso | 2009 |
How can the right FVIII dosage to neutralise low titre inhibitor be calculated?
|
JOURNAL OF THROMBOSIS AND HAEMOSTASIS |
Resumen congreso | 2009 |
Impact of FVIII product change in severe haemophilia A patients previously treated with plasma-derived FVIII
|
JOURNAL OF THROMBOSIS AND HAEMOSTASIS |
Resumen congreso | 2009 |
Integral assessment of female hemophilia carriers
|
JOURNAL OF THROMBOSIS AND HAEMOSTASIS |
Revisión | 2009 |
International recommendations on the diagnosis and treatment of patients with acquired hemophilia A
|
HAEMATOLOGICA |
Resumen congreso | 2009 |
Primary prophylaxis with recombinant factor VIIa (rFVIIa) in eleven haemophilia a patients with inhibitors younger than 3 years old
|
JOURNAL OF THROMBOSIS AND HAEMOSTASIS |
Resumen congreso | 2008 |
Pharmacokinetics of FVIII in clinical practice:: resource optimization and effect on health and quality of life in hemophilia A
|
HAEMOPHILIA |
Artículo | 2004 |
Control of Epstein-Barr virus load and lymphoproliferative disease by maintenance of CD8+ T lymphocytes in the T lymphocyte-depleted graft after bone marrow transplantation
|
JOURNAL OF INFECTIOUS DISEASES |
Resumen congreso | 1999 |
Mixed chimerism detected by VNTR-PCR is associated with a high incidence of relapse after selective CD4+ depletion plus adjusted CD8+ T-cell content in BMT
|
BONE MARROW TRANSPLANTATION |
Resumen congreso | 1998 |
Analysis of hematopoietic chimerism by VNTR-PCR after allogeneic bone marrow transplantation for acute leukemia
|
BLOOD |